NASDAQ:GRAY Graybug Vision (GRAY) Stock Forecast, Price & News $2.66 -0.07 (-2.56%) (As of 09/29/2023 ET) Add Compare Share Share Today's Range$2.54▼$2.7050-Day Range$2.64▼$5.5052-Week Range$5.00▼$22.12Volume1,319 shsAverage Volume2,165 shsMarket Capitalization$4.18 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaProfileChartCompetitorsEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Graybug Vision (NASDAQ:GRAY) StockGraybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly known as Graybug LLC and changed its name to Graybug Vision, Inc. in 2016. Graybug Vision, Inc. was incorporated in 2011 and is based in Redwood City, California.Read More GRAY Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GRAY Stock News HeadlinesAugust 3, 2023 | markets.businessinsider.comComplement Therapeutics Appoints Dr Parisa Zamiri MD, as Chief Medical OfficerJune 10, 2023 | appleinsider.comApple Vision Pro $3,499 mixed-reality headset launches at WWDC after years of rumorsOctober 1, 2023 | Legacy Research (Ad)Elon Did It Again: This Could be Bigger than TeslaLove him or hate him, it’s hard to deny Elon Musk is a genius. After revolutionizing online payment processing (PayPal), space exploration (SpaceX), and the auto industry (Tesla)... He’s getting ready to do it again with his new AI venture.March 28, 2023 | marketwatch.comOcular Drug Delivery Technology Market Outlook By 2031March 22, 2023 | finanznachrichten.deGraybug Vision, Inc. Announces Name and Trading Symbol ChangeMarch 21, 2023 | finanznachrichten.deGraybug Vision, Inc.: Graybug Announces Name and Trading Symbol ChangeMarch 21, 2023 | benzinga.comGraybug Vision Stock (NASDAQ:GRAY), DividendsMarch 20, 2023 | finance.yahoo.comCalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private PlacementOctober 1, 2023 | Stansberry Research (Ad)Bank Collapse Causes Gold Prices to SoarSilicon Valley Bank was the second-largest bank in American history to fail, and investors have started piling into the safety and security of gold. But if you're not taking advantage of a little-known way to invest for around $5 today, you're missing out.March 20, 2023 | finance.yahoo.comIndividual investors are Graybug Vision, Inc.'s (NASDAQ:GRAY) biggest owners and were hit after market cap dropped US$31mMarch 20, 2023 | finance.yahoo.comGraybug Announces Name and Trading Symbol ChangeFebruary 27, 2023 | marketwatch.comOcular Drug Delivery Technology Market is Booming Worldwide with Top Countries DataFebruary 14, 2023 | businesswire.comGRAYBUG VISION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graybug Vision, Inc. - GRAYFebruary 9, 2023 | finanznachrichten.deDelveInsight Business Research, LLP: The Global Ocular Drug Delivery System Market to Register Growth at a CAGR of ~7% by 2027 | DelveInsightFebruary 9, 2023 | yahoo.comThe Global Ocular Drug Delivery System Market to Register Growth at a CAGR of ~7% by 2027 | DelveInsightJanuary 25, 2023 | seekingalpha.comGRAY Graybug Vision, Inc.December 6, 2022 | markets.businessinsider.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMGO, GRAY, APEN, SALDecember 5, 2022 | wsj.comINVESTOR ALERT: The M&A Class Action Firm Announces the Investigation of Graybug Vision, Inc. - GRAYNovember 24, 2022 | benzinga.comGRAYBUG VISION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Graybug Vision, Inc. - GRAYNovember 22, 2022 | marketwatch.comGRAY STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Merger of Graybug Vision, Inc. Is Fair to ShareholdersNovember 22, 2022 | marketwatch.comGraybug Vision Shares Fall Premarket on CalciMedica Tie-Up >GRAYNovember 22, 2022 | benzinga.comShareholder Alert: Ademi LLP investigates whether Graybug Vision, Inc. has entered into a Fair Transaction with CalciMedicaNovember 22, 2022 | finance.yahoo.comGraybug Vision Agrees To Merge With Inflammatory Disease-Focused BiopharmaNovember 22, 2022 | finanznachrichten.deGraybug Vision, Inc.; CalciMedica Inc.: Graybug and CalciMedica Enter into Definitive Merger AgreementNovember 10, 2022 | finance.yahoo.comGraybug Vision Reports Financial Results for the Three and Nine Months Ended September 30, 2022September 16, 2022 | finance.yahoo.comDiality Names Pamela Wapnick as Chief Financial OfficerAugust 11, 2022 | msn.comGraybug Vision: Q2 Earnings InsightsSee More Headlines Receive GRAY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Graybug Vision and its competitors with MarketBeat's FREE daily newsletter. Email Address GRAY Company Calendar Last Earnings11/11/2021Today10/01/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:GRAY CUSIPN/A CIK1534133 Webwww.graybug.com PhoneN/AFaxN/AEmployees27Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($24.23) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-35,600,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-77.61% Return on Assets-71.34% Debt Debt-to-Equity RatioN/A Current Ratio10.73 Quick Ratio10.72 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.67 per share Price / Book1.59Miscellaneous Outstanding Shares1,571,000Free Float20,250,000Market Cap$4.18 million OptionableNot Optionable Beta1.20 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesDr. Frederic Guerard Pharm.D. (Age 49)Pres, CEO, Sec. & Director Comp: $931.02kMr. Robert S. Breuil (Age 60)CFO & Treasurer Comp: $577.47kDr. Gerald D. Cagle Ph.D. (Age 78)Sr. Advisor & Head of Bus. Devel. Comp: $44.67kDr. Parisa Zamiri M.D. (Age 57)Ph.D., Chief Medical Officer Comp: $662.11kDr. Peter A. Campochiaro M.D.Co-FounderDr. Peter J. McDonnell M.D. (Age 63)Co-Founder Ms. Bettina MaunzChief People Officer & Head of CommunicationsMr. Ming YangSr. VP of R&DDr. Ward M. Peterson Ph.D.Sr. VP of Preclinical Devel.Mr. Ali Kakavand Ph.D.VP & Head of Program ManagementMore ExecutivesKey CompetitorsBio-PathNASDAQ:BPTHZyVersa TherapeuticsNASDAQ:ZVSAEnsysce BiosciencesNASDAQ:ENSCCyclacel PharmaceuticalsNASDAQ:CYCCRevelation BiosciencesNASDAQ:REVBView All Competitors GRAY Stock - Frequently Asked Questions How have GRAY shares performed in 2023? Graybug Vision's stock was trading at $7.00 on January 1st, 2023. Since then, GRAY stock has decreased by 62.0% and is now trading at $2.6595. View the best growth stocks for 2023 here. How were Graybug Vision's earnings last quarter? Graybug Vision, Inc. (NASDAQ:GRAY) issued its quarterly earnings data on Thursday, November, 11th. The company reported ($5.32) earnings per share for the quarter, missing analysts' consensus estimates of ($5.18) by $0.14. When did Graybug Vision's stock split? Shares of Graybug Vision reverse split on the morning of Monday, March 20th 2023. The 1-14 reverse split was announced on Monday, March 20th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, March 20th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. When did Graybug Vision IPO? (GRAY) raised $75 million in an initial public offering on Friday, September 25th 2020. The company issued 4,700,000 shares at a price of $15.00-$17.00 per share. SVB Leerink and Piper Sandler acted as the underwriters for the IPO and Needham & Co. and Wedbush PacGrow were co-managers. What is Graybug Vision's stock symbol? Graybug Vision trades on the NASDAQ under the ticker symbol "GRAY." How do I buy shares of Graybug Vision? Shares of GRAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Graybug Vision's stock price today? One share of GRAY stock can currently be purchased for approximately $2.66. How much money does Graybug Vision make? Graybug Vision (NASDAQ:GRAY) has a market capitalization of $4.18 million. The company earns $-35,600,000.00 in net income (profit) each year or ($24.23) on an earnings per share basis. How can I contact Graybug Vision? The official website for the company is www.graybug.com. The company can be reached via email at ir@graybug.vision. This page (NASDAQ:GRAY) was last updated on 10/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Graybug Vision, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.